Cancer Diagnostics Market Global Share, Trend Analysis and Forecast Report

Cancer Diagnostics Market Report, By Technology, Application and Region-Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : 1782 | Publish Date : Upcoming | Industry : Healthcare | Geography : Global


  • Report Description
  • Summary

The global market for cancer diagnostics & technology is expected to grow rapidly owing to the rising awareness relating to cancer and its causes, expanding support by government as far as novel activities and financing, and the expanding healthcare consumption are additionally supporting the development of this market altogether. Going ahead, the approach of non-obtrusive screening systems and new diagnostic biomarkers are anticipated to open new income streams for market players sooner rather than later. However, the nonattendance of an appropriate repayment situation and the absence of talented experts in developing economies may obstruct the market throughout the following couple of years, reports the examination.

Cancer Diagnostics & Technology Market Segmental Overview

The global cancer diagnostics & technology market is segmented based on type of technology, application and geography. 

Cancer Diagnostics & Technology Market by Technology 

Based on technology, the cancer diagnostics market is categorised into platform-based and instrument-based. Platform-based technology consists of Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), Dna Microarrays, Flow Cytometry. Whereas, instrument-based technology includes imaging and biopsy. Imaging is further sub-segmented into Magentic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), Mammography and Ultrasound. The instrument-based segment is expected to hold a major share of the cancer diagnostics market in 2019. 

Cancer Diagnostics & Technology Market by Application 

Based on application, the global cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others. Breast cancer application is relied upon to represent a noteworthy offer of the cancer diagnostics market, by application in 2019. Breast cancer application is anticipated to have a significant share of the cancer diagnostics and technology market during the forecast period. 

Cancer Diagnostics & Technology Market by Geography 

The global cancer diagnostics & technology market is studied across key regions like North America, Europe, Asia Pacific, and Rest of the World. North America is anticipated to represent the biggest market share in the cancer diagnostics market, trailed by Europe and Asia. However, the Asian market is slated to develop at the highest CAGR in the coming five years and fills in as an income stash for the organizations working in the malignancy diagnostics showcase.

Cancer Diagnostic & Technology Market Key Players

Some of the major players operating in the cancer diagnostics & technology market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company, GE Healthcare, QIAGEN N.V., Abbott Laboratories, Inc., Roche Diagnostics, Siemens Healthcare, Philips Healthcare, C.R. Bard, Inc.

Why to buy this report:

  • The report offers changing market dynamics in the Cancer Diagnostics industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of Cancer Diagnostics market
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the Cancer Diagnostics market performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of Cancer Diagnostics market